Design and biological evaluation of substituted 5,7-dihydro-6H-indolo[2,3-c]quinolin-6-one as novel selective Haspin inhibitors. 2022

Sreenivas Avula, and Xudan Peng, and Xingfen Lang, and Micky Tortorella, and Béatrice Josselin, and Stéphane Bach, and Stephane Bourg, and Pascal Bonnet, and Frédéric Buron, and Sandrine Ruchaud, and Sylvain Routier, and Cleopatra Neagoie
Guangzhou Institute of Biomedicine and Health, Chinese Academy of Science, Guangzhou, China.

A library of substituted indolo[2,3-c]quinolone-6-ones was developed as simplified Lamellarin isosters. Synthesis was achieved from indole after a four-step pathway sequence involving iodination, a Suzuki-Miyaura cross-coupling reaction, and a reduction/lactamization sequence. The inhibitory activity of the 22 novel derivatives was assessed on Haspin kinase. Two of them possessed an IC50 of 1 and 2 nM with selectivity towards a panel of 10 other kinases including the parent kinases DYRK1A and CLK1. The most selective compound exerted additionally a very interesting cell effect on the osteosarcoma U-2 OS cell line.

UI MeSH Term Description Entries
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone
D017346 Protein Serine-Threonine Kinases A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors. Protein-Serine-Threonine Kinases,Serine-Threonine Protein Kinase,Serine-Threonine Protein Kinases,Protein-Serine Kinase,Protein-Serine-Threonine Kinase,Protein-Threonine Kinase,Serine Kinase,Serine-Threonine Kinase,Serine-Threonine Kinases,Threonine Kinase,Kinase, Protein-Serine,Kinase, Protein-Serine-Threonine,Kinase, Protein-Threonine,Kinase, Serine-Threonine,Kinases, Protein Serine-Threonine,Kinases, Protein-Serine-Threonine,Kinases, Serine-Threonine,Protein Kinase, Serine-Threonine,Protein Kinases, Serine-Threonine,Protein Serine Kinase,Protein Serine Threonine Kinase,Protein Serine Threonine Kinases,Protein Threonine Kinase,Serine Threonine Kinase,Serine Threonine Kinases,Serine Threonine Protein Kinase,Serine Threonine Protein Kinases
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein

Related Publications

Sreenivas Avula, and Xudan Peng, and Xingfen Lang, and Micky Tortorella, and Béatrice Josselin, and Stéphane Bach, and Stephane Bourg, and Pascal Bonnet, and Frédéric Buron, and Sandrine Ruchaud, and Sylvain Routier, and Cleopatra Neagoie
January 2019, Biological & pharmaceutical bulletin,
Sreenivas Avula, and Xudan Peng, and Xingfen Lang, and Micky Tortorella, and Béatrice Josselin, and Stéphane Bach, and Stephane Bourg, and Pascal Bonnet, and Frédéric Buron, and Sandrine Ruchaud, and Sylvain Routier, and Cleopatra Neagoie
November 2022, ACS medicinal chemistry letters,
Sreenivas Avula, and Xudan Peng, and Xingfen Lang, and Micky Tortorella, and Béatrice Josselin, and Stéphane Bach, and Stephane Bourg, and Pascal Bonnet, and Frédéric Buron, and Sandrine Ruchaud, and Sylvain Routier, and Cleopatra Neagoie
January 2002, Acta poloniae pharmaceutica,
Sreenivas Avula, and Xudan Peng, and Xingfen Lang, and Micky Tortorella, and Béatrice Josselin, and Stéphane Bach, and Stephane Bourg, and Pascal Bonnet, and Frédéric Buron, and Sandrine Ruchaud, and Sylvain Routier, and Cleopatra Neagoie
November 2019, Bioorganic chemistry,
Sreenivas Avula, and Xudan Peng, and Xingfen Lang, and Micky Tortorella, and Béatrice Josselin, and Stéphane Bach, and Stephane Bourg, and Pascal Bonnet, and Frédéric Buron, and Sandrine Ruchaud, and Sylvain Routier, and Cleopatra Neagoie
November 2021, Archiv der Pharmazie,
Sreenivas Avula, and Xudan Peng, and Xingfen Lang, and Micky Tortorella, and Béatrice Josselin, and Stéphane Bach, and Stephane Bourg, and Pascal Bonnet, and Frédéric Buron, and Sandrine Ruchaud, and Sylvain Routier, and Cleopatra Neagoie
May 2021, International journal of molecular sciences,
Sreenivas Avula, and Xudan Peng, and Xingfen Lang, and Micky Tortorella, and Béatrice Josselin, and Stéphane Bach, and Stephane Bourg, and Pascal Bonnet, and Frédéric Buron, and Sandrine Ruchaud, and Sylvain Routier, and Cleopatra Neagoie
January 2024, Bioorganic & medicinal chemistry letters,
Sreenivas Avula, and Xudan Peng, and Xingfen Lang, and Micky Tortorella, and Béatrice Josselin, and Stéphane Bach, and Stephane Bourg, and Pascal Bonnet, and Frédéric Buron, and Sandrine Ruchaud, and Sylvain Routier, and Cleopatra Neagoie
December 2006, Bioorganic & medicinal chemistry,
Sreenivas Avula, and Xudan Peng, and Xingfen Lang, and Micky Tortorella, and Béatrice Josselin, and Stéphane Bach, and Stephane Bourg, and Pascal Bonnet, and Frédéric Buron, and Sandrine Ruchaud, and Sylvain Routier, and Cleopatra Neagoie
October 2014, Bioorganic & medicinal chemistry,
Sreenivas Avula, and Xudan Peng, and Xingfen Lang, and Micky Tortorella, and Béatrice Josselin, and Stéphane Bach, and Stephane Bourg, and Pascal Bonnet, and Frédéric Buron, and Sandrine Ruchaud, and Sylvain Routier, and Cleopatra Neagoie
January 2017, Organic letters,
Copied contents to your clipboard!